GLP-1 course compounds. Semaglutide, tirzepatide, and liraglutide are authorised medicinal products in the Netherlands and have elevated regulatory and import scrutiny. Any framing that provides them as therapeutic options to prescription medicines brings them under the Geneesmiddelenwet and its advertising principles, which the IGJ actively enforc